$XYL
Xylem Inc.

2023 Q2 Form 10-Q Financial Statement

#000152447223000018 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $1.722B $1.448B
YoY Change 26.25% 13.84%
Cost Of Revenue $1.071B $902.0M
YoY Change 26.9% 12.05%
Gross Profit $651.0M $546.0M
YoY Change 25.19% 16.92%
Gross Profit Margin 37.8% 37.71%
Selling, General & Admin $407.0M $354.0M
YoY Change 29.62% 16.45%
% of Gross Profit 62.52% 64.84%
Research & Development $58.00M $53.00M
YoY Change 9.43% 1.92%
% of Gross Profit 8.91% 9.71%
Depreciation & Amortization $92.00M $60.00M
YoY Change 55.93% 3.45%
% of Gross Profit 14.13% 10.99%
Operating Expenses $465.0M $407.0M
YoY Change 26.7% 14.33%
Operating Profit $186.0M $131.0M
YoY Change 27.4% 18.02%
Interest Expense -$12.00M $9.000M
YoY Change -200.0% -30.77%
% of Operating Profit -6.45% 6.87%
Other Income/Expense, Net $7.000M $4.000M
YoY Change 250.0% -500.0%
Pretax Income $114.0M $126.0M
YoY Change -16.18% 28.57%
Income Tax $22.00M $27.00M
% Of Pretax Income 19.3% 21.43%
Net Earnings $92.00M $99.00M
YoY Change -17.86% 20.73%
Net Earnings / Revenue 5.34% 6.84%
Basic Earnings Per Share $0.45 $0.55
Diluted Earnings Per Share $0.45 $0.54
COMMON SHARES
Basic Shares Outstanding 180.6M shares 180.3M shares
Diluted Shares Outstanding 206.7M shares 181.3M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $708.0M $837.0M
YoY Change -36.39% -25.07%
Cash & Equivalents $708.0M $837.0M
Short-Term Investments
Other Short-Term Assets $225.0M $193.0M
YoY Change 21.62% 3.76%
Inventory $1.143B $857.0M
Prepaid Expenses
Receivables $1.659B $1.123B
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.735B $3.010B
YoY Change 17.67% -3.46%
LONG-TERM ASSETS
Property, Plant & Equipment $1.144B $631.0M
YoY Change 88.16% -0.79%
Goodwill $7.108B $2.738B
YoY Change 161.9% -1.58%
Intangibles $3.188B $915.0M
YoY Change 226.97% -8.68%
Long-Term Investments
YoY Change
Other Assets $922.0M $646.0M
YoY Change 28.41% -5.14%
Total Long-Term Assets $12.36B $4.930B
YoY Change 146.5% -3.35%
TOTAL ASSETS
Total Short-Term Assets $3.735B $3.010B
Total Long-Term Assets $12.36B $4.930B
Total Assets $16.10B $7.940B
YoY Change 96.57% -3.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $968.0M $710.0M
YoY Change 49.38% 8.9%
Accrued Expenses $622.0M $784.0M
YoY Change -20.46% 9.96%
Deferred Revenue
YoY Change
Short-Term Debt $75.00M $0.00
YoY Change
Long-Term Debt Due $165.0M
YoY Change -68.33%
Total Short-Term Liabilities $2.282B $1.494B
YoY Change 16.97% -22.19%
LONG-TERM LIABILITIES
Long-Term Debt $2.267B $1.881B
YoY Change 20.65% 0.16%
Other Long-Term Liabilities $900.0M $761.0M
YoY Change 4.17% -18.35%
Total Long-Term Liabilities $3.167B $1.881B
YoY Change 68.55% 0.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.282B $1.494B
Total Long-Term Liabilities $3.167B $1.881B
Total Liabilities $6.198B $4.351B
YoY Change 24.31% -13.21%
SHAREHOLDERS EQUITY
Retained Earnings $2.344B $2.331B
YoY Change 4.74% 6.88%
Common Stock $8.498B $2.154B
YoY Change 302.18% 2.52%
Preferred Stock
YoY Change
Treasury Stock (at cost) $717.0M $716.0M
YoY Change 1.27% 1.27%
Treasury Stock Shares
Shareholders Equity $9.899B $3.578B
YoY Change
Total Liabilities & Shareholders Equity $16.10B $7.940B
YoY Change 96.57% -3.39%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $92.00M $99.00M
YoY Change -17.86% 20.73%
Depreciation, Depletion And Amortization $92.00M $60.00M
YoY Change 55.93% 3.45%
Cash From Operating Activities $28.00M -$19.00M
YoY Change -75.22% -76.54%
INVESTING ACTIVITIES
Capital Expenditures $54.00M $49.00M
YoY Change -217.39% -200.0%
Acquisitions
YoY Change
Other Investing Activities -$398.0M $1.000M
YoY Change -8060.0% -116.67%
Cash From Investing Activities -$452.0M -$37.00M
YoY Change 1002.44% -13.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities 298.0M -$63.00M
YoY Change -673.08% -40.57%
NET CHANGE
Cash From Operating Activities 28.00M -$19.00M
Cash From Investing Activities -452.0M -$37.00M
Cash From Financing Activities 298.0M -$63.00M
Net Change In Cash -126.0M -$107.0M
YoY Change -730.0% -53.88%
FREE CASH FLOW
Cash From Operating Activities $28.00M -$19.00M
Capital Expenditures $54.00M $49.00M
Free Cash Flow -$26.00M -$68.00M
YoY Change -116.35% 112.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001524472
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-35229
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Xylem Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IN
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2080495
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
301 Water Street SE
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Washington
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
DC
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20003
CY2023Q1 dei City Area Code
CityAreaCode
(202)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
869-9150
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
XYL
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
180616578 shares
CY2023Q1 us-gaap Revenues
Revenues
1448000000 usd
CY2022Q1 us-gaap Revenues
Revenues
1272000000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
902000000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
805000000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
546000000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
467000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
354000000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
304000000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53000000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52000000 usd
CY2023Q1 xyl Restructuring And Asset Impairment Losses
RestructuringAndAssetImpairmentLosses
8000000 usd
CY2022Q1 xyl Restructuring And Asset Impairment Losses
RestructuringAndAssetImpairmentLosses
0 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
131000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
111000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
9000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
13000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
1000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
126000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
98000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
99000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
82000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180400000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181300000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181000000.0 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
99000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
82000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
22000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-3000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
4000000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-6000000 usd
CY2023Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
5000000 usd
CY2022Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
2000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
-1000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
4000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
30000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-3000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-5000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
3000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
35000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
134000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
76000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
837000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
944000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
36000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
50000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1123000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1096000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
857000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
799000000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
193000000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
173000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3010000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3012000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
631000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
630000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2738000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2719000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
915000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
930000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
646000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
661000000 usd
CY2023Q1 us-gaap Assets
Assets
7940000000 usd
CY2022Q4 us-gaap Assets
Assets
7952000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
710000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
723000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
784000000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
867000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1494000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1590000000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1881000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1880000000 usd
CY2023Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
285000000 usd
CY2022Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
286000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
215000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
222000000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
476000000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
471000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
4351000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4449000000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000.0 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000.0 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196500000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196000000.0 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2000000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2152000000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2134000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2331000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2292000000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15900000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15800000 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
716000000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
708000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-191000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-226000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3578000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3494000000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
11000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
9000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3589000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3503000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7940000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7952000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
99000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
82000000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
28000000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
28000000 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
32000000 usd
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
30000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9000000 usd
CY2023Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
8000000 usd
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
1000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
6000000 usd
CY2022Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
3000000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
28000000 usd
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
64000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
55000000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
106000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20000000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-98000000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-79000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-81000000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
49000000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
49000000 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
1000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2000000 usd
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
4000000 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6000000 usd
CY2023Q1 us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
11000000 usd
CY2022Q1 us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
7000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
51000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
60000000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
55000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-63000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-106000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12000000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-107000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-232000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
944000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1349000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
837000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1117000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
11000000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
23000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
49000000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15000000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2023Q1 xyl Purchase Obligation Supplier Finance Program Termination Notice Required
PurchaseObligationSupplierFinanceProgramTerminationNoticeRequired
P30D
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
121000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1383000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1222000000 usd
CY2023Q1 xyl Other Revenues
OtherRevenues
65000000 usd
CY2022Q1 xyl Other Revenues
OtherRevenues
50000000 usd
CY2023Q1 us-gaap Revenues
Revenues
1448000000 usd
CY2022Q1 us-gaap Revenues
Revenues
1272000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1383000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1222000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1383000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1222000000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
151000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
183000000 usd
CY2023Q1 xyl Contract With Customer Asset New Contract Additions
ContractWithCustomerAssetNewContractAdditions
48000000 usd
CY2023Q1 xyl Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
58000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-50000000 usd
CY2023Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
48000000 usd
CY2023Q1 xyl Contract With Customer Asset Other
ContractWithCustomerAssetOther
0 usd
CY2023Q1 xyl Contract With Customer Liability Other
ContractWithCustomerLiabilityOther
0 usd
CY2023Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
151000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
191000000 usd
CY2021Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
125000000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
164000000 usd
CY2022Q1 xyl Contract With Customer Asset New Contract Additions
ContractWithCustomerAssetNewContractAdditions
34000000 usd
CY2022Q1 xyl Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
62000000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-50000000 usd
CY2022Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
39000000 usd
CY2022Q1 xyl Contract With Customer Asset Other
ContractWithCustomerAssetOther
-2000000 usd
CY2022Q1 xyl Contract With Customer Liability Other
ContractWithCustomerLiabilityOther
-1000000 usd
CY2022Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
118000000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
175000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
447000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P60M
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
6000000 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
6000000 usd
CY2022Q1 us-gaap Severance Costs1
SeveranceCosts1
0 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
6000000 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2000000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 xyl Asset Impairmentand Restructuring Charges
AssetImpairmentandRestructuringCharges
8000000 usd
CY2022Q1 xyl Asset Impairmentand Restructuring Charges
AssetImpairmentandRestructuringCharges
0 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
10000000 usd
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
7000000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
6000000 usd
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
3000000 usd
CY2023Q1 xyl Restructuring Reserve Asset Impairment
RestructuringReserveAssetImpairment
0 usd
CY2022Q1 xyl Restructuring Reserve Asset Impairment
RestructuringReserveAssetImpairment
0 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
10000000 usd
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
4000000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16000000 usd
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.164
CY2022Q2 us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
800000000 sek
CY2022Q2 us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
77000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
99000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
180371000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
180205000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
25000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
26000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180396000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180231000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181319000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181021000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
314000000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
286000000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
71000000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
58000000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
472000000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
455000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
857000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
799000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2719000000 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
19000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2738000000 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1793000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
878000000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
915000000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1770000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
840000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
930000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32000000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30000000 usd
CY2023Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
3000000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
867000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
216000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
285000000 usd
CY2023Q1 xyl Customer Related Liabilities Current
CustomerRelatedLiabilitiesCurrent
222000000 usd
CY2022Q4 xyl Customer Related Liabilities Current
CustomerRelatedLiabilitiesCurrent
210000000 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
156000000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
186000000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
69000000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
37000000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
37000000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
86000000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
80000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
784000000 usd
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
19000000 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
20000000 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1881000000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1880000000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
0 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
0 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1881000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1880000000 usd
CY2023Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
3000000 usd
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
7000000 usd
CY2023Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
5000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3503000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
99000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
35000000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
2000000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
CY2022Q3 us-gaap Dividends Cash
DividendsCash
60000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3589000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3226000000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
82000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000000 usd
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q3 us-gaap Dividends Cash
DividendsCash
55000000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4000000 usd
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
45000000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3206000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3000000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1935000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
67.55
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
83000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
227000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
101.09
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
132000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
48.39
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
102.22
CY2023Q1 xyl Share Based Compensation Arrangement By Share Based Payment Award Other Changes In Stock Option Activity Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherChangesInStockOptionActivityNumberOfShares
14000 shares
CY2023Q1 xyl Share Based Compensation Arrangement By Share Based Payment Award Weighted Average Exercise Price Other Changes To Option Activity
ShareBasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageExercisePriceOtherChangesToOptionActivity
73.16
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2040000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
72.48
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
66000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1495000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
65.08
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M18D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
59000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1962000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
71.53
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y10M24D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
65000000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
7000000 usd
CY2023Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
4000000 usd
CY2022Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
5000000 usd
CY2023Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
426000000 usd
CY2022Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
451000000 usd
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies Gross
AccrualForEnvironmentalLossContingenciesGross
4000000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
54000000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
57000000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
6000000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
5000000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6000000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
6000000 usd
CY2023Q1 xyl Standard Product Warranty Accrual Other
StandardProductWarrantyAccrualOther
-1000000 usd
CY2022Q1 xyl Standard Product Warranty Accrual Other
StandardProductWarrantyAccrualOther
0 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
55000000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
56000000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 us-gaap Revenues
Revenues
1448000000 usd
CY2022Q1 us-gaap Revenues
Revenues
1272000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
131000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
111000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
9000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
13000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
1000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
126000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
98000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
60000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
58000000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
49000000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
49000000 usd

Files In Submission

Name View Source Status
0001524472-23-000018-index-headers.html Edgar Link pending
0001524472-23-000018-index.html Edgar Link pending
0001524472-23-000018.txt Edgar Link pending
0001524472-23-000018-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_1.jpg Edgar Link pending
image_11.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xyl-20230331.htm Edgar Link pending
xyl-20230331.xsd Edgar Link pending
xyl03302022ex322.htm Edgar Link pending
xyl03312023ex101.htm Edgar Link pending
xyl03312023ex102.htm Edgar Link pending
xyl03312023ex103.htm Edgar Link pending
xyl03312023ex104.htm Edgar Link pending
xyl03312023ex105.htm Edgar Link pending
xyl03312023ex311.htm Edgar Link pending
xyl03312023ex312.htm Edgar Link pending
xyl03312023ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
xyl-20230331_cal.xml Edgar Link unprocessable
xyl-20230331_def.xml Edgar Link unprocessable
xyl-20230331_lab.xml Edgar Link unprocessable
xyl-20230331_pre.xml Edgar Link unprocessable
xyl-20230331_htm.xml Edgar Link completed